日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia

胰岛素德谷与胰岛素甘精U100对1型糖尿病合并复发性夜间严重低血糖患者持续血糖监测期间记录的血糖指标的影响

期刊:Journal of diabetes science and technology
影响因子:3.7
doi:10.1177/19322968231197423
Brøsen, Julie Maria Bøggild; Agesen, Rikke Mette; Alibegovic, Amra Ciric; Andersen, Henrik Ullits; Beck-Nielsen, Henning; Gustenhoff, Peter; Hansen, Troels Krarup; Hedetoft, Christoffer; Jensen, Tonny Joran; Juhl, Claus Bogh; Stolberg, Charlotte Røn; Lerche, Susanne Søgaard; Nørgaard, Kirsten; Parving, Hans-Henrik; Tarnow, Lise; Thorsteinsson, Birger; Pedersen-Bjergaard, Ulrik
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria

肾纤维化标志物与2型糖尿病合并微量白蛋白尿患者的炎症和肾功能恶化有关。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0283296
Poulsen, Christina Gjerlev; Rasmussen, Daniel G K; Genovese, Federica; Hansen, Tine W; Nielsen, Signe Holm; Reinhard, Henrik; von Scholten, Bernt Johan; Jacobsen, Peter K; Parving, Hans-Henrik; Karsdal, Morten Asser; Rossing, Peter; Frimodt-Møller, Marie
炎症/感染
糖尿病
炎症
代谢
发表日期：2023
文献求助 收藏

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial

比较德谷胰岛素和甘精胰岛素U100治疗易发生夜间严重低血糖的1型糖尿病患者的疗效：HypoDeg随机、对照、开放标签、交叉试验

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14574
Pedersen-Bjergaard, Ulrik; Agesen, Rikke M; Brøsen, Julie M B; Alibegovic, Amra C; Andersen, Henrik U; Beck-Nielsen, Henning; Gustenhoff, Peter; Hansen, Troels K; Hedetoft, Christoffer; Jensen, Tonny J; Juhl, Claus B; Jensen, Andreas K; Lerche, Susanne S; Nørgaard, Kirsten; Parving, Hans-Henrik; Sørensen, Anne L; Tarnow, Lise; Thorsteinsson, Birger
代谢
糖尿病
免疫/内分泌
发表日期：2022
文献求助 收藏

Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

有机阴离子转运蛋白基因变异与糖尿病肾病患者血浆中阿曲生坦的暴露量及长期疗效相关

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.2721
Smeijer, J David; Koomen, Jeroen V; Kohan, Donald E; McMurray, John J V; Bakris, George L; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Makino, Hirofumi; Mayer, Gert; Nowicki, Michal; Perkovic, Vlado; Rossing, Peter; Tobe, Sheldon; Parving, Hans-Henrik; de Zeeuw, Dick; Heerspink, Hiddo J L
代谢
糖尿病肾病
糖尿病
发表日期：2022
文献求助 收藏

Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial

内皮素受体拮抗剂治疗期间蛋白尿的早期反应和长期肾脏保护：SONAR试验的预设分析

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.2021030391
Heerspink, Hiddo J L; Xie, Di; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Perkovic, Vlado; Rossing, Peter; Parving, Hans-Henrik; de Zeeuw, Dick
信号转导
发表日期：2021
文献求助 收藏

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

临床试验入组前eGFR下降的患者间差异较大及其对阿曲生坦疗效的影响：SONAR试验的事后分析

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.2021040498
Waijer, Simke W; de Vries, Sieta T; Busch, Robert; Xie, Di; Gansevoort, Ron T; Hou, Fan Fan; Górriz, Jose L; Laverman, Gozewijn D; De Nicola, Luca; Pascual, Julio; Provenzano, Michele; Pergola, Pablo E; Tang, Sydney C W; Wanner, Christoph; Zaoui, Philippe; Parving, Hans-Henrik; de Zeeuw, Dick; Heerspink, Hiddo J L
发表日期：2021
文献求助 收藏

The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Randomized Trial

阿曲生坦对肾脏和心力衰竭结局的影响（按基线蛋白尿和肾功能分层）：SONAR随机试验的事后分析

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.07340521
Waijer, Simke W; Gansevoort, Ron T; Bakris, George L; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kohan, Donald E; Kitzman, Dalane W; Makino, Hirofumi; McMurray, John J V; Perkovic, Vlado; Tobe, Sheldon; Parving, Hans-Henrik; de Zeeuw, Dick; Heerspink, Hiddo J L
心力衰竭
心血管
发表日期：2021
文献求助 收藏

Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial

阿曲生坦暴露量的个体间差异部分解释了肾脏保护和体液潴留反应的差异：SONAR试验的事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14252
Koomen, Jeroen V; Stevens, Jasper; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Parving, Hans-Henrik; Perkovic, Vlado; Tobe, Sheldon W; de Zeeuw, Dick; Heerspink, Hiddo J L
发表日期：2021
文献求助 收藏

Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease

个体阿曲生坦暴露与2型糖尿病合并慢性肾病患者的长期肾脏和心力衰竭预后相关

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.2143
Koomen, Jeroen V; Stevens, Jasper; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan Fan; Kitzman, Dalane W; Kohan, Donald E; Makino, Hirofumi; McMurray, John J V; Parving, Hans-Henrik; Perkovic, Vlado; Tobe, Sheldon W; de Zeeuw, Dick; Heerspink, Hiddo J L
心血管
代谢
心力衰竭
糖尿病
发表日期：2021
文献求助 收藏

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-study

厄贝沙坦治疗不影响2型糖尿病合并微量白蛋白尿患者血浆中二羰基化合物甲基乙二醛、乙二醛和3-脱氧葡萄糖酮的水平：一项IRMA2子研究

期刊:Diabetic Medicine
影响因子:3.4
doi:10.1111/dme.14405
Piazza, M; Hanssen, N M J; Persson, F; Scheijen, J L; van de Waarenburg, M P H; van Greevenbroek, M M J; Rossing, P; Hovind, P; Stehouwer, C D A; Parving, H-H; Schalkwijk, C G
代谢
糖尿病
发表日期：2021
文献求助 收藏